Viewpoints

This section provides a space for coalition members to share short pieces that provide an expert opinion or a perspective on an issue related to COVID-19 clinical research.

If you would like to join the coalition, fill this form.

Read the viewpoint guidelines to find out how to submit a viewpoint.

We need context-specific evidence to inform public health pandemic strategies in low-resource settings: A consideration of lockdowns

1 December 202112 January 2022

Nearly two years into the COVID-19 pandemic, Dr Wilber Sabiiti, co-chair of the coalition's Virology, Immunology and Diagnostics Working Group, makes a case for the need to strengthen context-specific evidence generation to guide pandemic strategies. In this Viewpoint, he looks at diverging approaches in Uganda and Tanzania, in their use of national lockdowns.

A TRIPS waiver is urgently needed to make progress on COVID-19 vaccine equity

15 July 202121 July 2021

The coalition's Social Science Working Group and co-signatories have published a viewpoint on vaccine equity, arguing that a temporary TRIPS waiver is needed for COVID-19 vaccines and other medicines. Vaccine inequity is amongst the most significant social justice issues of our generation, and it poses a major threat to the global COVID-19 response. Urgent action is needed to improve equity and bring an end to the COVID-19 pandemic, including in low- and middle-income countries.